Call for Abstract

World Congress on Pediatric Oncology & Care, will be organized around the theme “Pediatric Oncology- A Step Towards Child Care”

Pediatric Oncology Congress is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pediatric Oncology Congress

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pediatric Oncology is the branch of medicine which deals with the diagnosis and treatment of cancer in children. It is the most challenging for specialties because, despite successful treatment of many children, there is a high death rate still connected with different sorts of illness. Pediatric Oncology incorporate Pediatric Immunology, Genetics in Pediatric Oncology, Pediatric Oncology Diagnosis, Therapies in Pediatric Oncology, Pediatric Nursing Care,  Pediatric Cancer Surgery, Pediatric Oncology Drugs, Pediatric Orthopedic Oncology, Pediatrics Drug Toxicity, Pediatric Cancer, Pharmacology Pediatric Cancer Care, Obesity in Pediatric oncology, Pediatric Oncology Metabolism, Neonatal and Perinatal Nursing, Pediatric Neuro-Oncology, Clinical Trials.

 

Pediatric immunology is a branch of medical specialty that deals with immunologic or allergic disorders of youngsters. As system acts as a significant role in identification of the spy and make the defense, kids with immunological disorder are a lot of at risk of cancers. There are many varieties of organs in our body that plays important role in immunologic functions.  The organs embrace thymus, bone marrow, spleen and tonsils. Medical specialty touches each medical specialty subspecialty. Most closely aligned to hypersensitivity reaction and medical specialty, medical specialty conjointly has shut ties to infectious diseases, hematology, and medicine

Genetic predisposition for childhood cancer is under diagnosis. Syndrome-specific screening programs may lead to early detection of a further independent malignancy. Cancer policy investigation may additionally be guaranteed for affected relatives and detection of a change will leave procreative subject matter. Genetic testing in pediatric medicine is of  interest to the families, and therefore the overwhelming majority opts for investigation into probably underlying CPSs. Trio sequencing provides distinctive insights into Hertz in pediatric cancers and is progressively changing into a standard approach in fashionable medicine, and thus, trio sequencing wants additionally to be integrated habitually into the observe of pediatric medicine, Because the understanding of the genetic etiology of childhood cancers will increase, the necessity for the involvement of specialists at home with the availability of counseling for this population is predominant.

 

Doctors use many tests to diagnose, cancer. They do tests to learn. If cancer has spread to another part of the body from where it started, it is called metastasis. For most types of cancer, a biopsy is the only sure way for the doctor to know whether an area of the body has cancer. In addition to a physical examination, the following tests may be used to diagnose childhood cancer: Blood tests, Biopsy Bone marrow aspiration, Lumbar puncture (spinal tap), Ultrasound Computed tomography (CT or CAT) scan, Magnetic resonance imaging (MRI), Positron emission tomography (PET) or PET-CT scan, Scans or radioisotope studies. Pediatric diagnostic radiation uses medical imaging to diagnose medical conditions in children

Complementary and alternative medicine is increasing in use in the pediatric oncology population. Evidence on the science of complementary and alternative medicine (CAM) in children with cancer is slowly evolving. Most parents of children with cancer want their children to receive state-of-the-art therapy, which generally includes chemotherapy, radiation, and surgery. A growing body of literature in adult oncology provides evidence for the role of CAM to help manage symptoms and reduce distress. Translating this research to children requires studies with new models that address family roles and include measurement of outcomes relevant to children’s developmental stages and unique responses. 

 

A medical specialty nurse could be a nursing skilled that primarily works within the field of medical specialty. Medical specialty nurses usually add a team of medical specialty tending professionals. This includes pediatricians, medical specialty specialists, and alternative medical specialty nurses. The role of medical specialty nurses is to administer directly procedures and medicines to kids in keeping with prescribed medical aid plans. Medical specialty nurses square measure expected to own fast reaction and quick response on nerve-wracking things to contain the grievous things. They must be practiced in handling varied trauma, injury or malady cases while not lease the patients feel the urgency of true, helpful patients with wholesome care, quickly identification conditions and providing on-spot solutions, administering the proper medications to attenuate pain.

 

Surgery is one of the cornerstones of cancer treatments. The goal of surgical oncology is to physically remove as much of the tumor as safely possible.Pediatric surgeons collaborate with pediatric hematologists and oncologists to deliver compassionate care based on the latest medical advances. Pediatric surgeons use minimal access surgery (laparoscopy for abdominal surgery and thoracoscopy for chest surgery) to diagnose and treat certain types of pediatric cancer. These special techniques can, in many cases, improve our diagnostic capabilities and add to the comfort of young patients with cancer. Apart from surgery there are Chemotherapy Radiation therapy, High-dose chemotherapy/radiation therapy and stem cell transplant, Retinoid therapy, Immunotherapy.

 

Oncology drugs are targeted to specific organs or locations in the body. Approval of new cancer drugs for pediatric patients generally occurs after their development and approval for treating adult cancers. As most drug development occurs in the industry setting, the relatively small market of pediatric oncology does not provide the financial incentives for companies to actively pursue pediatric oncology solutions. Larotrectinib is the first cancer drug to receive FDA breakthrough therapy designation for patients with a specific fusion of two genes in the cancer cell, no matter what cancer type. The research appears in The Lancet Oncology. To understand challenges in childhood cancer drug development better, how all of biomedical research is supported at the national and international levels needs to be considered. In the USA, approximately 60% of funding for biomedical research stems from the private biopharmaceutical sector.

Specializing in Pediatric Bone and Soft Tissue Masses. The Division of Orthopedic Oncology at the Alvin & Lois Lepidus Cancer Institute provides highly specialized care for children, adolescents and adults with bone and soft tissue tumors including cancers that have spread from other sites in the body. Orthopedic Oncology offers expert care to children and adults diagnosed with tumors and tumor-like conditions of the bone and soft tissue, including bone metastases, sarcomas, benign and cancerous tumors of the bone or soft tissue and pathologic fractures. The Musculoskeletal Oncology Service specializes in treating soft tissue and bone tumors of the limbs, pelvis, and shoulders, benign and malignant tumors, metastatic disease of bone, primary bone malignancy, sarcoma, and pathologic fractures due to malignancy in children and adults. 

 

Toxic exposures occur frequently in children throughout the world. Common patterns of pediatric poisoning consist of exploratory ingestions in children younger than six years of age and intentional ingestions and recreational drug use in older children and adolescents. Drug treatment in children differs from that in adults, most obviously because it is usually based on weight or surface area. Doses (and dosing intervals) differ because of age-related variations in drug absorption, distribution, metabolism, and elimination (see Pharmacokinetics in Children). A child cannot safely receive an adult drug dose, nor can it be assumed that a child’s dose is proportional to an adult’s dose (i.e, that a 7-kg child requires 1/10 the dose of a 70-kg adult).  Considering the relatively high percentage of toxic exposures that involve drugs, it is fortunate that only a few medications are truly life-threatening to a young child who ingests only one or two pills or one to two teaspoon-sized swallows. None of the medications listed in Table 2 will injure every exposed child.

 

Numerous studies have documented that adolescents and young adults (AYAs) expertise major cancer burden moreover as significant cancer mortality compared with alternative age teams. The explanations for the disparate outcomes of AYAs and alternative age teams don't seem to be fully understood and square measure doubtless to be complex, together with a spread of sociodemographic problems distinctive to those people moreover as variations between adolescents, younger medicine patients, and adults within the medicine of metastatic tumor agents. As a result of adolescence may be an amount of transition from childhood to early adulthood, various physical, physiological, cognitive, and activity changes occur throughout this point. Adolescents square measure distinctive in many ways. This is often an announcement few would ail, and it holds true among the sector of medical specialty. From their most rife neoplasm sorts to their outcomes, adolescents square measure totally different from their younger medicine counterparts

There square measure several imaging interventions necessary for medical specialty medicine patients, range of interventions as well as transcutaneous diagnostic test for solid tumour and hematological malignancy of complications of immunological disorder similar to invasive respiratory organ aspergillosis. Tumor imaging embody tumor detection, tumor characterization and medical diagnosis, imaging-guided diagnostic test, analysis of tumour extent and staging, assessment of treatment responses, and police work for residual tumour or tumour return. In clinical observe, numerous mixtures of imaging modalities square measure wont come through these goals. Recently introduced tumor imaging ways, similar to diffusion MRI, intromission MRI, whole-body MRI, and antilepton emission pictorial representation (PET-CT), have shown promising results.

 

Cancer Care Ontario is the Ontario government’s principal cancer advisor and a division of CCO. We equip health professionals, organizations and policy-makers with the most up-to-date cancer knowledge and tools to prevent cancer and deliver high-quality patient care. Collect and analyze data about cancer services and combine it with evidence and research that is shared with the healthcare community in the form of guidelines and standards, Monitor and measure the performance of the cancer system. Oversee a funding and governance model that ties funding to performance, making healthcare providers more accountable and ensuring value for investments in the system, engage cancer patients and their families in the design, delivery and evaluation of Ontario’s cancer system.

 

The definition of childhood cancer sometimes includes adolescents between 15–19 years old. Pediatric oncology is the branch of medicine concerned with the diagnosis and treatment of cancer in children. In many developed countries the incidence is slowly increasing, as rates of childhood cancer increased by 0.6% per year between 1975 and 2002 in the United States and by 1.1% per year between 1978 and 1997 in Europe. The main subtypes of brain and central nervous system tumors in children are: astrocytoma, brain stem glioma, craniopharyngioma, desmoplastic infantile ganglioglioma, ependymoma, high-grade glioma, medulloblastoma and atypical teratoid rhabdoid tumor. Premature heart disease is a major long-term complication in adult survivors of childhood cancer. Adult survivors are eight times more likely to die of heart disease than other people, and more than half of children treated for cancer develop some type of cardiac abnormality, although this may be asymptomatic or too mild to qualify for a clinical diagnosis of heart disease

obesity may increase the risk of cancer are not well understood, but it is believed that the combined effects of the adipose tissue environment and the endocrine alterations that accompany it among obese people both interact to promote tumor initiation and progression. Adipose tissue also creates an inflammatory environment that enhances the ability of tumor cells to metastasize. One of the main ways in which obesity can cause cancer is by promoting chronic low-level inflammation, which can, over time, cause DNA damage that leads to cancer. Articles supporting this view were reviewed by Cerda et al.[10] There are also a number of hormonal, metabolic and other changes caused by obesity that may affect carcinogenesis. A review by Tahergorabi et al. summarizes articles indicating that obesity induces changes in angiogenesis, inflammation, interaction of proinflammatory cytokines, endocrine hormones, adipokines including leptin and adiponectin, insulin, growth factors, estrogen, progesterone and cell metabolism.

 

In children with cancer, suboptimal nutrition states are common consequences of the disease and its treatment. These nutrition states have been attributed to a number of etiologies dependent on the patient’s tumor type and treatment and are associated with increased morbidity and mortality. Interventions vary from psychosocial to pharmacological and surgical management. Further research is necessary to understand the epidemiology and etiology of these nutrition states. Of great importance is the development and implementation of effective interventions to optimize nutritional status among children with cancer during and after therapy. It remains difficult to derive a clear understanding of the prevalence of malnutrition because most studies have focused on children with leukemia where generally small sample sizes have been used and various methods have been employed to assess nutritional status. The etiologies of weight loss and malnutrition at diagnosis are variable; possible causes are energy deficiency and/or inflammation leading to loss of fat and fat free mass. Table I lists factors associated with malnutrition risk in children with cancer based on tumor type, treatment modality, and patient demographics

Neonatal nursing is a subspecialty of nursing when babies are taken care up to twenty-eight days after birth. Babe nursing needs a high level of skills, devotion and ardent quality because the nurses tend to babies with a scope of problems, prematureness, birth defects, disease, vas abnormalities and surgical problems. Child nurses area unit an important piece of the babe care cluster and area unit needed to understand basic child revival, have the capability to manage the infant's temperature and shrewdness to begin viscous and pulse oximetry watching. Some perinatal restorative overseers add midwifery and medicine work environments to supply care to a girl within the thick of her physiological condition, whereas others add labor and transport to present a secured, sturdy condition for work, and facilitate different social protection suppliers within the thick of a woman's work and movement. Babe nursing could be a sub specialty of nursing that works with babies perceived with Associate in nursing assortment of problems running from rashness, birth surrenders, contamination, heart deformities, and surgical problems. The time of life is characterized because the main month of life; be that because it could, these babies area unit debilitated for a substantial length of your time.

 

Pediatric Neuro-Oncology is the management of children with brain and spinal cord tumors. Pediatric brain cancers can be stubborn, and typically do not respond to traditional chemotherapy and radiation. in part because the brain is somewhat protected from medications (the blood-brain barrier), in part because surgery in the brain has to be quite refined to minimize injury to brain tissue, and in part because radiation treatment to the brain can cause injury to normal brain tissue.  To successfully manage and treat children with these tumors it takes a team of practitioners specifically focused on this area. Treatment of brain tumors in children can be very different from treatment in adults. It is currently a vibrant field of research. This is desperately needed, since brain tumors have become the number one cause of cancer-related mortality in children. The thorough understanding of the immense biological heterogeneity of childhood brain tumors is a prerequisite for targeted treatment approaches. Thus, we will continue to comprehensively investigate the entire genetic and epigenetic diversity of childhood brain tumors within and across histopathological entities. Many of these novel methods are currently being prepared for routine diagnostic applications in a clinical setting through our nationally and internationally acting molecular diagnostics programs. 

 

As a result of ongoing research and better supportive care, the treatment of childhood malignancies has dramatically improved survival in developed countries. The same cannot be said about the all-important nutritional care of the child with cancer as much still needs to be done to reach the ultimate goal, namely to provide evidence based nutritional intervention that will contribute to further improvements in optimal outcomes. Furthermore, in developing countries, especially in Low Income Countries, malnutrition is only one aspect of socioeconomic disadvantages that are associated negatively with many components of cancer control, from access to care, through to treatment compliance, to long-term follow-up. In these settings economic evaluations of nutritional support in the form of cost-effectiveness and cost-utility analyses, would be logical undertakings.

 

Clinical trials are experiments or observations done in clinical research. They are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people. Clinical trials produce the best data available for health care decision making. The purpose of clinical trials is research, so the studies follow strict scientific standards. These standards protect patients and help produce reliable study results. Clinical trials are one of the final stages of a long and careful research process. The process often begins in a laboratory, where scientists first develop and test new ideas. Clinical studies observe people in normal settings. Researchers gather information, group volunteers according to broad characteristics, and compare changes over time. Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention.